Objective
To determine the role of ITPKC in the pathogenesis of KD.
Methods
To assess the role of ITPKC in lymphocyte activation, mouse splenocytes were stimulated with superantigen and T-cell proliferation, cytokines production, Ca 2+ flux and ITPKC protein expression were measured by 3 H thymidine, ELISA, flow cytometry, and Western blot, respectively. To confirm the results in a human system, lymphocyte activation was determined in a human cell line after siRNA knockdown.
Results
ITPKC was upregulated at both mRNA and protein levels by mouse splenocytes following superantigen stimulation. Cyclosporin A inhibition of Ca 2+ /NFAT signalling abolished T-cell proliferation and cytokine production following superantigen activation. ITPKC knockdown in superantigen activated human lymphocyte cell line could not completely inhibit cytokine production or Ca 2+ flux.
Conclusion
Although ITPKC and the Ca 2+ /NFAT signalling pathway were activated in lymphocytes following superantigen stimulation, inhibition of ITPKC was not able to alter lymphocyte activation or Ca 2+ flux pointing to overlapping or compensatory pathways. These findings may account for the conflicting reports on the association between ITPKC polymorphisms and KD in different ethnicities. 
